Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$433.6K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| Mar 10 | TRDA | Entrada Therapeutics, Inc. | SSELL◷ | 11,388 | $13.02 | $148.2K | -8.6% | Open the original filing on SEC.gov |
| Mar 9 | TRDA | Entrada Therapeutics, Inc. | SSELL◷ | 5,089 | $13.00 | $66.2K | -3.7% | Open the original filing on SEC.gov |
| Mar 4 | TRDA | Entrada Therapeutics, Inc. | SSELL◷ | 7,988 | $12.25 | $97.9K | -5.5% | Open the original filing on SEC.gov |
| Mar 3 | TRDA | Entrada Therapeutics, Inc. | FTAX | 5,712 | $11.76 | $67.2K | -3.8% | Open the original filing on SEC.gov |
| Mar 2 | TRDA | Entrada Therapeutics, Inc. | FTAX | 2,939 | $11.66 | $34.3K | -1.9% | Open the original filing on SEC.gov |
| Mar 1 | TRDA | Entrada Therapeutics, Inc. | AGRANT◆ | 66,600 | — | — | — | Open the original filing on SEC.gov |
| Mar 1 | TRDA | Entrada Therapeutics, Inc. | AGRANT | 44,600 | — | — | +40.5% | Open the original filing on SEC.gov |
| Nov 21, 2025 | TRDA | Entrada Therapeutics, Inc. | SSELL◷ | 8,910 | $9.98 | $88.9K | -7.5% | Open the original filing on SEC.gov |
| Sep 2, 2025 | TRDA | Entrada Therapeutics, Inc. | FTAX | 1,734 | $5.43 | $9.4K | -1.4% | Open the original filing on SEC.gov |